252 related articles for article (PubMed ID: 26125105)
21. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
23. Cancer and Systemic Lupus Erythematosus.
Ladouceur A; Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
Rheum Dis Clin North Am; 2020 Aug; 46(3):533-550. PubMed ID: 32631602
[TBL] [Abstract][Full Text] [Related]
24. Systemic lupus erythematosus and malignancies: a review article.
Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
Rheum Dis Clin North Am; 2014 Aug; 40(3):497-506, viii. PubMed ID: 25034158
[TBL] [Abstract][Full Text] [Related]
25. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
26. Lupus and cancer.
Gayed M; Bernatsky S; Ramsey-Goldman R; Clarke A; Gordon C
Lupus; 2009 May; 18(6):479-85. PubMed ID: 19395448
[TBL] [Abstract][Full Text] [Related]
27. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
28. An update on autoantibodies in systemic lupus erythematosus.
Gómez-Bañuelos E; Fava A; Andrade F
Curr Opin Rheumatol; 2023 Mar; 35(2):61-67. PubMed ID: 36695053
[TBL] [Abstract][Full Text] [Related]
29. Systemic lupus erythematosus and Hodgkin's lymphoma.
Bhalla R; Ajmani HS; Kim WW; Swedler WI; Lazarevic MB; Skosey JL
J Rheumatol; 1993 Aug; 20(8):1316-20. PubMed ID: 8230011
[TBL] [Abstract][Full Text] [Related]
30. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
31. Higher mortality risk from gynaecological neoplasms and non-Hodgkin's lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry.
Moreno-Torres V; Martínez-Urbistondo M; Vázquez-Comendador J; Mateos Seirul-Lo M; Castejón R; Huerta A; Durán-Del Campo P; Tutor P; Mellor-Pita S
Lupus Sci Med; 2024 Apr; 11(1):. PubMed ID: 38631847
[TBL] [Abstract][Full Text] [Related]
32. Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
Johnson DK; Reynolds KM; Poole BD; Montierth MD; Todd VM; Barnado A; Davis MF
PLoS One; 2021; 16(1):e0243150. PubMed ID: 33481783
[TBL] [Abstract][Full Text] [Related]
33. Malignancy in systemic lupus erythematosus: a report of five cases in a series of 96 patients.
Lopez Dupla M; Khamashta M; Pintado Garcia V; Lavilla Uriol P; Valencia Ortega E; Gil Aguado A
Lupus; 1993 Dec; 2(6):377-80. PubMed ID: 8136821
[TBL] [Abstract][Full Text] [Related]
34. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
35. Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival.
Kariniemi S; Rantalaiho V; Virta LJ; Kautiainen H; Puolakka K; Elfving P
Lupus; 2022 Dec; 31(14):1750-1758. PubMed ID: 36200539
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Gordon C; Clarke AE
Int J Cancer; 2011 Dec; 129(12):2966-9. PubMed ID: 21448902
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus and malignancies risk.
Mao S; Shen H; Zhang J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):253-62. PubMed ID: 26319223
[TBL] [Abstract][Full Text] [Related]
38. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
Wang LH; Wang WM; Lin SH; Shieh CC
Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
[TBL] [Abstract][Full Text] [Related]
39. Risk of malignancy in women with systemic lupus erythematosus.
Sweeney DM; Manzi S; Janosky J; Selvaggi KJ; Ferri W; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
